Thursday 6 December 2018

A new Approach -
Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with recurrent vulvovaginal candidiasis (RVVC)

#clinicaltrials19 #Brisbane #Australia
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)